Monash projects backed by Australia's national biotech incubator – India Education | Latest Education News | Global Educational News

Biotech projects being led by Monash University have received $2.5M in funding to advance novel therapeutics and preclinical medical research that address schizophrenia, cancer, inflammatory diseases, chronic obstructive pulmonary disease and muscula

Related Keywords

Australia ,Monash ,South Australia ,Kathy Nielsen ,Simon Wilkins ,Ross Dickins ,Chris Langmead ,Merlin Thomas ,Jonathan Baell ,Nadia Kershaw ,Gregory Stewart ,Peter Currie ,Australian Regenerative Medicine Institute Monash University ,Eliza Hall Institute ,Monash University ,Commonwealth Government Medical Research Future Fund ,Monash Institute Of Pharmaceutical Sciences ,Central Clinical School ,Australia National University Prof ,Business Development Life Sciences ,Ip Group ,Monash Investment Holdings ,Monash Institute Of Pharmaceutical Sciences Prof ,Research Commercialisation Initiative ,Central Clinical School Monash University ,Professor Chris Langmead ,Monash Institute ,Professor Peter Currie ,Associate Professor Mika ,Australian Regenerative Medicine Institute ,Associate Professor Ross Dickins ,Pharmaceutical Sciences ,Australia National University ,Phil Board ,Professor Merlin Thomas ,Central Clinical ,Monash Investment ,Commonwealth Government ,Medical Research Future Fund ,Medical Research Commercialisation Initiative ,Brandon Biocatalyst ,University Chief Commercialisation Officer ,Monash Innovation ,Business Development ,Life Sciences ,